KAHR medical Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:KAHR medical Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10791
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
KAHR medical Ltd (KAHR), a subsidiary of Hadasit Bio-Holdings Ltd, is a drug manufacturing company that develops fusion protein pharmaceuticals. The company’s drug development pipeline is built around Dual Signaling Proteins (DSP) technology. Its pipeline products comprise DSP105, DSP106 and DSP107. KAHR’s DSP 105 is a targeted immune activation leading to T-cell mediated tumor destruction. The company’s products are used in multiple animal disease models for the treatment of cancer and autoimmune diseases and also links portions of two immune and cancer-related membrane proteins to develop fusion protein. KAHR is headquartered in Jerusalem, Israel.

KAHR medical Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
KAHR medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
KAHR medical Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
KAHR medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
KAHR medical Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
KAHR medical Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
KAHR medical Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Kahr Medical Raised USD12 Million in Series B Equity Financing 10
Kahr Medical To Raise US$2.5 Million In Venture Financing 11
Partnerships 13
Cobra Biologics Enters Into Co-Development Agreement With Kahr Medical For KAHR-101 And KAHR-102 13
KAHR medical Ltd – Key Competitors 14
KAHR medical Ltd – Key Employees 15
KAHR medical Ltd – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
KAHR medical Ltd, Pharmaceuticals & Healthcare, Key Facts 2
KAHR medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
KAHR medical Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
KAHR medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
KAHR medical Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
KAHR medical Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Kahr Medical Raised USD12 Million in Series B Equity Financing 10
Kahr Medical To Raise US$2.5 Million In Venture Financing 11
Cobra Biologics Enters Into Co-Development Agreement With Kahr Medical For KAHR-101 And KAHR-102 13
KAHR medical Ltd, Key Competitors 14
KAHR medical Ltd, Key Employees 15

List of Figures
KAHR medical Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
KAHR medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
KAHR medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
KAHR medical Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
KAHR medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
KAHR medical Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
KAHR medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
KAHR medical Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[KAHR medical Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Samil Pharmaceutical Co., Ltd. (000520):企業の財務及び戦略的SWOT分析
    Summary Samil Pharmaceutical Co., Ltd. (Samil) is a pharmaceutical company that produces and supplies indispensable medicines. The company offers central nervous system drugs, ophthalmic drugs, respiratory drugs, genito-urinary drugs, antibiotics in chemotherapeutics, circulatory drugs, gastro-intes …
  • Petrel Resources Plc (PET):企業の財務及び戦略的SWOT分析
    Summary Petrel Resources Plc (Petrel Resources) is an oil and gas company that carries out exploration and production of crude oil and natural gas in Iraq. The company’s areas of operations include Subba and Luhais in Southern Iraq, Tano Basin in Ghana, and Porcupine Basin in Ireland. It also has op …
  • Event Hospitality & Entertainment Ltd:企業の戦略・SWOT・財務情報
    Event Hospitality & Entertainment Ltd - Strategy, SWOT and Corporate Finance Report Summary Event Hospitality & Entertainment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Ceylon Hospitals PLC (CHL.N0000):企業財務及び戦略的SWOT分析
    Summary Ceylon Hospitals PLC (Durdans Hospitals) is a healthcare service provider that offers various medical and patient care services. The hospital offers services such as speech and language therapy, dental care, ENT care, emergency care, plastic and reconstructive surgery, laparoscopic surgery, …
  • Rotary Engineering Limited:企業の戦略・SWOT・財務分析
    SummaryRotary Engineering Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • GlobalSCAPE, Inc. (GSB):企業財務及び戦略的SWOT分析
    Summary GlobalSCAPE, Inc. (GlobalSCAPE) is a technology company that offers secure information exchange solutions. The company offers products such as managed file transfer, secure email, file replication and synchronization, secure FTP, and secure mobile file sharing. It offers services such as eme …
  • Wai Yuen Tong Medicine Holdings Limited (897):企業の財務及び戦略的SWOT分析
    Summary Wai Yuen Tong Medicine Holdings Limited (Wai Yuen Tong) is a pharmaceutical company that develops a diverse range of Chinese and western medicinal products. The company manufactures, processes and retails traditional Chinese medicine, western pharmaceutical, health food and personal care pro …
  • Derma Sciences, Inc. (DSCI):企業のM&A・提携動向(医療機器分野)
    Summary Derma Sciences, Inc. (Derma Sciences) is a tissue regeneration company. It focuses on advanced burn and wound care. Its advanced wound care product portfolio includes Its product portfolio consists of novel patented dressings, barrier dressings, proprietary antimicrobial dressing, proprietar …
  • Huayi Brothers Media Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Huayi Brothers Media Corporatio …
  • CK Infrastructure Holdings Ltd (1038):企業の財務・戦略的SWOT分析
    CK Infrastructure Holdings Ltd (1038) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Dundee Real Estate Investment Trust:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Dundee Real Estate Investment T …
  • Trellis Bioscience Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Trellis Bioscience Inc (Trellis) is a drug development company that discovers and develops human antibody therapeutics for the treatment of bacterial and viral infectious diseases and cancer indications. The company’s clinical candidate includes TRL1068, which targets and disintegrates bacte …
  • Medline Industries Inc-製薬・医療分野:企業M&A・提携分析
    Summary Medline Industries Inc (Medline) is one of the leading manufacturers and distributors of healthcare supplies in the US. It distributes products to diverse end users including hospitals, extended care facilities, surgery centers, home care dealers, home care agencies, commercial laundries, ph …
  • Square Pharmaceuticals Ltd. (SQURPHARMA):企業の財務及び戦略的SWOT分析
    Summary Square Pharmaceuticals Ltd. (Square) is a pharmaceutical company that manufactures pharmaceutical, herbal and nutraceuticals products. The company offers products such as alimentary preparations, anesthetics,anti-asthma, anti-epileptic, anti-erectile dysfunction agent, laxative,anti-obesity …
  • Gibson Energy Inc (GEI)-石油・ガス分野:企業M&A・提携分析
    Summary Gibson Energy Inc. (Gibson) is an independent midstream energy company that provides integrated services to the oil and gas industry. The company transport, store, blend, process, market and distribute crude oil, condensate, natural gas liquids (NGLs), water, oilfield waste, and refined prod …
  • Tofas Turk Otomobil Fabrikasi A.S.:企業の戦略・SWOT・財務分析
    Tofas Turk Otomobil Fabrikasi A.S. - Strategy, SWOT and Corporate Finance Report Summary Tofas Turk Otomobil Fabrikasi A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Yue Yuen Industrial (Holdings) Limited:企業の戦略・SWOT・財務分析
    SummaryYue Yuen Industrial (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of t …
  • Arizona Public Service Company:企業のM&A・提携動向(発電分野)
    Summary Arizona Public Service Company (APS) a subsidiary of Pinnacle West Capital Corporation, is an energy utility that generates, procures, transmits, and distributes electricity. The company generates electricity from coal, nuclear, gas, oil, and renewable sources such as solar, wind, geothermal …
  • Pennant International Group plc (PEN):企業財務及び戦略的SWOT分析
    Summary Pennant International Group plc (Pennant) is a technology company that offers information services, training systems, and software services to its customers. The company provides supportability engineering software products, and LSAR software. Its services include emulation and simulation, p …
  • Shangri-La Hotels (Malaysia) Berhad:企業の戦略・SWOT・財務情報
    Shangri-La Hotels (Malaysia) Berhad - Strategy, SWOT and Corporate Finance Report Summary Shangri-La Hotels (Malaysia) Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆